SCHEMBL3846702

SCHEMBL3846702

Cc1cc2nccn2cc1-c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)nc1-c1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.39
TGFBR1 P36897 9/20 0.38
CSNK1D P48730 3/20 0.33
CSNK1E P49674 3/20 0.33
MAPK13 O15264 1/20 0.33
MAPK12 P53778 1/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33
MAP4K4 O95819 1/20 0.32
EGFR P00533 1/20 0.32
FRK P42685 1/20 0.32
MAPK9 P45984 1/20 0.32
CSNK1A1 P48729 1/20 0.32
POLB P06746 1/20 0.32
ADORA2A P29274 2/20 0.32
ADORA2B P29275 2/20 0.32
ADORA1 P30542 2/20 0.32
NAMPT P43490 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845543 0.84 TGFBR1 (0.47) TGFBR1ADORA2AADORA2BADORA1NAMPT
SCHEMBL3846676 0.82 ADORA2A (0.36) TGFBR1CSNK1DCSNK1EMAPK13MAPK12
SCHEMBL3846704 0.82 RORC (0.34) RORCTGFBR1
SCHEMBL3850256 0.80 FLT3 (0.34) CSNK1DCSNK1EMAPK11MAPK14
SCHEMBL3849569 0.78 CDK1 (0.36) TGFBR1CSNK1DCSNK1EMAPK13MAPK12
SCHEMBL3850113 0.76 SMN1; SMN2 (0.38) TGFBR1CSNK1DCSNK1EMAPK13MAPK12
SCHEMBL13874255 0.76 TGFBR1 (0.42) RORCTGFBR1POLBADORA2ANAMPT
SCHEMBL3851177 0.74 TGFBR1 (0.47) TGFBR1ADORA2AADORA2BADORA1
SCHEMBL3847660 0.73 TGFBR1 (0.43) TGFBR1
SCHEMBL3852193 0.73 TGFBR1 (0.40) TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed